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Background: Preoperative jaundice is frequent in gallbladder cancer (GBC) and indicates advanced disease.
Resection is rarely recommended to treat advanced GBC. An aggressive surgical approach for advanced GBC
remains lacking because of the association of this disease with serious postoperative complications and poor
prognosis. This study aims to re-assess the prognostic value of jaundice for the morbidity, mortality, and survival
of GBC patients who underwent surgical resection with curative intent.
Methods: GBC patients who underwent surgical resection with curative intent at a single institution between
January 2003 and December 2012 were identified from a prospectively maintained database.
Results: A total of 192 patients underwent surgical resection with curative intent, of whom 47 had preoperative
jaundice and 145 had none. Compared with the non-jaundiced patients, the jaundiced patients had significantly
longer operative time (p < 0.001) and more intra-operative bleeding (p = 0.001), frequent combined resections of
adjacent organs (23.4% vs. 2.8%, p = 0.001), and postoperative complications (12.4% vs. 34%, p = 0.001). Multivariate
analysis showed that preoperative jaundice was the only independent predictor of postoperative complications.
The jaundiced patients had lower survival rates than the non-jaundiced patients (p < 0.001). However, lymph node
metastasis and gallbladder neck tumors were the only significant risk factors of poor prognosis. Non-curative resection
was the only independent predictor of poor prognosis among the jaundiced patients. The survival rates of the jaundiced
patients with preoperative biliary drainage (PBD) were similar to those of the jaundiced patients without PBD (p = 0.968).
No significant differences in the rate of postoperative intra-abdominal abscesses were found between the jaundiced
patients with and without PBD (n = 4, 21.1% vs. n = 5, 17.9%, p = 0.787).
Conclusions: Preoperative jaundice indicates poor prognosis and high postoperative morbidity but is not a surgical
contraindication. Gallbladder neck tumors significantly increase the surgical difficulty and reduce the opportunities for
radical resection. Gallbladder neck tumors can independently predict poor outcome. PBD correlates with neither a low
rate of postoperative intra-abdominal abscesses nor a high survival rate.
Keywords: Gallbladder cancer, Jaundice, Curative resection, Preoperative biliary drainage, Prognosis* Correspondence: weicelia@163.com; shenfengdfgd@yahoo.com.cn
†Equal contributors
1Eastern Hepatobiliary Surgery Hospital, Second Military Medical University,
Changhai Road 225, Shanghai 200438, China
Full list of author information is available at the end of the article
© 2014 yang et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Yang et al. BMC Cancer 2014, 14:652 Page 2 of 13
http://www.biomedcentral.com/1471-2407/14/652Background
The gallbladder is the most common site for biliary tract
cancers. Most gallbladder cancer (GBC) patients have
advanced disease at presentation, thus preventing
curative resection and indicating poor prognosis [1-3].
However, recent advances in the understanding of its
epidemiology and pathogenesis coupled with the devel-
opment of newer diagnostic tools and therapeutic
options have resulted in an enhanced optimism toward
GBC management.
Curative resection provides the only chance for long-
term survival [3]. However, most GBC patients have ad-
vanced disease at presentation because of late detection
caused by non-specific symptomatology [4]. An aggres-
sive tumor rapidly spreads in an anatomically “busy”
area, making it unresectable [4]. Jaundice in GBC usually
results from the infiltration of the extrahepatic bile duct
by cancer and indicates advanced stage [1-3]. Numerous
surgeons, especially those in Western countries, consider
jaundice to be a contraindication of resection despite the
consensus that surgical resection offers the only chance
for long-term survival [4-6]. Furthermore, recent studies
have shown that jaundice and extrahepatic bile duct in-
volvement are independent predictors of poor outcome
in GBC [3,4,7]. Resection is rarely recommended to treat
advanced GBC [8,9]. An aggressive surgical approach
for advanced GBC remains lacking because of the
association of this disease with serious postoperative
complications and poor prognosis. Only a few studies
have reported successful surgical resection of jaun-
diced GBC patients and evaluated the prognostic value
of preoperative jaundice [2,8,9]. Most of these studies
investigated small numbers of cases.
This study retrospectively analyzed the postoperative
mortality, morbidity, and long-term survival of jaundiced
and non-jaundiced GBC patients. This study aims to
assess the safety and indications of curative resection in
jaundiced GBC patients and to confirm that preoperative
jaundice is not always a surgical contraindication.
Methods
GBC patients who underwent surgical resection with
curative intent at the Eastern Hepatobiliary Hospital
institution between January 2003 and December 2012
were identified from a prospectively maintained hepato-
biliary surgery database. Permission from the Second
Military Medical University’s Institutional Review Board
was obtained prior to data review. Written informed
consents were obtained from all patients for surgical
treatment and pathological examinations according to
the institutional guidelines.
Surgical resection with curative intent was classified as
either R0 or R1 [8]. According to the tumor–node–metas-
tasis staging system of the International Union AgainstCancer (UICC)/American Joint Committee on Cancer, 13
regional lymph nodes [gallbladder, pericholedochal, hep-
atic pedicle, proper hepatic artery (HA), and periportal
nodes] were considered to be N1. Involvement of the
periaortic, pericaval, superior mesenteric artery, and/or ce-
liac artery lymph nodes were classified as N2. Involvement
of inter-aortocaval lymph nodes was considered as M1
[4,10]. Routine sampling of inter-aortocaval lymph nodes
was not performed in the present study.
Between January 2003 and December 2012, 392 BGC
patients were surgically treated at our unit, 192 of whom
underwent resection with curative intent (overall cura-
tive resection rate: 48.9%). Of these 192 patients, 47
(24.5%) had preoperative jaundice. All patients who
underwent either palliative or exploratory surgery were
excluded from the analysis. Extensive invasion to the
hepatoduodenal ligament, excessive presence of liver or
peritoneal metastases beyond areas near the gallbladder,
or bulky lymph node metastases were considered as sur-
gical contraindications.Preoperative liver optimization
Patients were considered jaundiced when clinical jaun-
dice was present upon initial examination and confirmed
by elevated serum bilirubin level (>2.0 mg/dL). Of the
47 jaundiced GBC patients who underwent curative
intent procedures, 19 underwent preoperative biliary
drainage (PBD). Percutaneous transhepatic biliary drain-
age (PTBD) was performed in 10 patients (10/19;
52.6%). Endoscopic biliary drainage was performed in 9
patients (9/19; 47.4%). This intervention was performed
approximately a week before hepatectomy based on the
revaluation of hepatic function and the selection of the
surgeon. No patient underwent preoperative portal vein
embolization.Operative procedures
Our center’s surgical policy for GBC involves radical sur-
gery. For radical surgery, a partial hepatectomy with en
bloc resection of GB and a dissection of regional lymph
nodes (lymph nodes along the hepatoduodenal ligament
and common HA and behind the pancreatic head) were
routinely conducted (Figure 1). Partial hepatectomy
includes extended right/left hepatectomy, right trisec-
tionectomy, or wedge resection with a 2 cm margin
(including segments IVb/V). Even advanced GBC was
considered a candidate for resection as long as it could
be anatomically removed. Extrahepatic bile duct resec-
tion was performed when the preoperative diagnostic
images showed a tumor affecting the extrahepatic bile
duct or when a tumor was significantly close to or in-
vaded the extrahepatic bile duct upon intraoperative
inspection (Figure 2).
Figure 1 Typical operative field after wedge resection with a 2 cm
margin (including segments IVb/V) and skeletonization of the
hepatoduodenal ligament. We state that the subject of the
photograph has given written informed consent by the patient to
publication of the photograph. PV, portal vein; IVC, inferior vena cava;
PHA, proper hepatic artery; RHA, right hepatic artery; LHA, left hepatic
artery; MHA, middle hepatic artery; GDA, gastroduodenal artery
Figure 2 Typical imaging feature of gallbladder carcinoma
involving the hepatic hilum. a. Enhanced CT shows gallbladder
carcinoma with hepatic invasion. b. Preoperative MRCP shows that
gallbladder carcinoma is located in the neck invading the hepatic hilum.
The right hepatic artery and the common bile duct were involved by
tumor in the surgery. We state that the subject of the photograph has
given written informed consent by the patient to publication of the
photograph. GB, gallbladder, CHD, common hepatic duct; IVC, inferior
vena cava; PV, portal vein; PD, pancreatic duct.
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en bloc using major hepatectomy, pancreatoduodenectomy,
partial gastrectomy, partial duodenal resection, partial colon
resection, and/or portal vein/hepatic arterial resection and
reconstruction as long as R0 resection was expected.
Surgeons assisted pathologists to correctly identify
resection margins during the preparation of sections in
fixed specimens. Surgical resection was considered to
have curative intent (R0 or R1) when the whole tumor
was resected, such that no macroscopically residual
tumor could be detected. Stage grouping was performed
according to the pTNM classification system of UICC,
7th edition [10].
Adjuvant therapy was given to 28 patients: intraoperative
chemotherapy in 18 patients, postoperative chemotherapy
in 15 patients (including a combination of intraoperative
and postoperative chemotherapy in 13), postoperative
radiotherapy in 15 patients, and a combination of chemo-
therapy and radiotherapy in 7 patients.
Statistical analysis
The overall survival was measured from the date of
operation to death, including deaths caused by cancer or
other causes, or until the last day of follow-up. The two
groups were compared using Student’s t test for para-
metric data and the Mann-Whitney U test for non-
parametric data. The Chi-square test was used for cat-
egorical data. Survival curves were generated using the
Kaplan–Meier method and compared using the log-rank
test. Cox regression analysis was performed to determine
which factor is the best prognostic determinant. Statis-
tical significance was considered at p < 0.05. Statisticalanalyses were performed using SPSS Version 17.0 for
Windows (SPSS, Inc., Chicago, IL, USA).
Results
Demographic data
Of the 192 GBC patients managed with curative intent
during the 10-year inclusion period, 47 were jaundiced,
of whom 21 were men and 26 were women. The median
age of the jaundiced patients was 57.5 years (range: 35 −
80 years). No significant differences in risk factors and
in-hospital mortality were observed between the jaun-
diced and non-jaundiced patients (Table 1). Microscopic
invasion of the liver parenchyma and lymph node metas-
tasis were more frequent in the jaundiced patients than
in the non-jaundiced patients, but the difference was not
significant (p = 0.183 and p = 0.091). An advanced T
category was associated with preoperative jaundice (p =
0.019), suggesting more serious local tumor invasions in
Table 1 Demographic data of jaundiced (n = 47) and non-jaundiced GBC patients (n = 145)
Jaundiced, n Non-jaundiced, n p-value
Male gender 21 45 0.088
Mean age (range) 57.5 ± 11.0(35-80) 58.2 ± 10.2(23-83) 0.725
Postoperative hospital stay 19.7 ± 13.3 (4–85) 11.5 ± 6.4 (5–51) < 0.001
Associated gallbladder disease 0.983
Gallstones 26 (55.3%) 80 (55.2%)
Gallbladder polyp 1 (2.1%) 3 (2.0%)
Nil 20 (42.6%) 62 (42.8%)
Tumor location < 0.001
Gallbladder neck 28 (59.6) 26 (17.9)
Gallbladder body 10 (21.3) 70 (48.3)
Gallbladder fundus 9 (19.1) 49 (33.8)
Histologic type 0.259
Well differentiated 2 (4.3) 9 (6.2)
Moderately differentiated 41 (87.2) 109 (75.2)
Poorly differentiated 4 (8.5) 27 (18.6)
Extent of liver resection 0.590
Major hepatectomy (>3 segments) 4 4
Anatomical segments IV-V 8 42
Gallbladder bed 35 99
Extrahepatic bile duct resection 44 (93.6) 12 (8.3%) < 0.001
Pathologic extrahepatic bile duct invasion 38 (80.9) 12 (8.3%) < 0.001
Combined resection of adjacent organs 11 (23.4%) 4 (2.8%) < 0.001
Hepatic invasion 26 (55.3%) 64 (44.1%) 0.183
Lymph node metastasis 30 (63.8%) 72 (49.7%) 0.091
Vascular invasion 2 (4.3) 3 (2.1%) 0.415
pT 0.019
pT1-2 16 (34.1%) 78 (53.8%)
pT3-4 31 (65.9%) 67 (46.2%)
Intra-operative bleeding (mL) 754.3 ± 600.9 (200–3200) 386.0 ± 251.8(200–1800) 0.001
Operative time (min) 310.0 ± 82.7 (100–470) 224.3 ± 77.3(100–400) < 0.001
R0 36 (76.6%) 127 (87.6%) 0.068
Mortality (number of patients) 3 (6.4%) 3 (2.1%) 0.141
Morbidity (need invasive treatment) 16 (34.0%) 18 (12.4%) 0.001
Note that adjacent organs include the pancreas, duodenum, stomach, and/or colon other than the liver and extrahepatic bile duct.
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tients. More intra-operative bleeding and longer opera-
tive times were observed in the jaundiced patients than
in the non-jaundiced patients (p = 0.001 and p < 0.001,
respectively). This result suggests that more lesion re-
sections were performed on the jaundiced patients
than on the non-jaundiced patients. Hence, the com-
bined resection of adjacent organs (CRAO) was more
frequent in the jaundiced patients than in the non-
jaundiced patients to achieve curative resection (p =
0.001). However, the R0 resection rates were similarbetween the jaundiced and non-jaundiced patients
(p = 0.068).
Surgical procedures
Table 1 summarizes the surgical procedures. In this
study, “major hepatectomy” indicates right or left hepa-
tectomy, extended right or left hepatectomy, or right or
left trisegmentectomy while “minor hepatectomy” indicates
segmental resection or less. Parenchymal transection was
performed under HA and portal vein clamping for 15 min
at 5 min intervals. Hepatectomy was performed in all 192
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tomy, including one patient with combined caudate lobe
resection, three patients with partial portal vein (PV) re-
section, and two patients with HA resection and recon-
struction. The following combined resections of other
organs were performed in 15 patients: pancreatoduode-
nectomy (n = 2), wedge duodenal resection (n = 1), seg-
mental colon resection (n = 1), partial kidney resection
(n = 1), and partial gastrectomy (n = 10).
All patients underwent en bloc dissection of the re-
gional lymph nodes (lymph nodes along the hepatoduo-
denal ligament and common hepatic artery and behind
the pancreatic head). Morbidity was significantly lower
in the non-jaundiced patients than in the jaundiced
patients (12.4% vs. 34.0%, p = 0.001). Compared with
the non-jaundiced patients, the jaundiced patients hadTable 2 Univariate and multivariate analyses for hospital mor
with curative intent (n = 192)
Variables No. of patients Morbid
Gender
Female 126 18 (14.3
Male 66 16 (24.2
Age
< 60 years 107 17 (15.9
≥ 60 years 85 17 (20.0
Preoperative jaundice
Present 47 16 (34.0
Absent 145 18 (12.4
Major hepatectomy
Yes 8 4 (50.0%
No 184 30 (16.3
Extrahepatic bile duct resection
With 56 17 (30.4
Without 136 17 (12.5
Combined resection of adjacent organs (CRAO)
With 15 7 (46.7%
Without 177 27 (15.3
Combined portal vein/hepatic artery resection
With 5 1 (20.0%
Without 187 33 (17.6
Operative time 0.280
< 240 min 87 9 (10.3%
≥ 240 min 105 25 (23.8
Intraoperative blood infusion 0.056
With 44
Without 148
Adjacent organs include the pancreas, duodenum, stomach, and/or colon other thasignificantly longer operative times (p < 0.001) and more
intra-operative bleeding (p = 0.001), advanced T category
(p = 0.019), common bile duct resections (93.6% vs.
8.3%, p < 0.001), extensive pathologic extrahepatic bile duct
invasion (pEBI) (80.9% vs. 8.3%, p = 0.001), and frequent
CRAOs (23.4% vs. 2.8%, p = 0.001) (Table 1). However,
no significant differences in major hepatectomies and R0
resection were observed between the jaundiced and non-
jaundiced patients (8.5% vs. 2.8%, p = 0.590 and 76.6% vs.
87.6%, p = 0.068).
Mortality and morbidity in 192 GBC patients who
underwent curative intent procedures (Table 2)
The postoperative mortality and morbidity rates of the
192 GBC patients were 3.1% (n = 6) and 17.7% (n = 34),
respectively. Postoperative complications were graded Itality in GBC patients who underwent surgical resection
ity Univariate Multivariate

























n the liver and bile duct.
Table 3 Univariate analyses for hospital mortality in GBC






Female 26 14 (36.8%)
Male 21 2 (22.2%)
Age 0.927
< 57 years 26 6 (31.6%)
≥ 57 years 21 10 (35.7%)
pEBI 0.405
Yes 38 2 (50.0%)
No 9 14 (32.6%)
Preoperative biliary drainage 0.769
Yes 19 15 (34.1%)
No 28 1 (33.3%)
Major hepatectomy 0.481
Yes 4 5 (45.5%)
No 43 11 (30.6%)
Extrahepatic bile duct resection 0.979
With 44 1 (50.0%)
Without 3 15 (33.3%)
CRAO 0.361
With 11 8 (44.4%)
Without 36 8 (27.6%)




< 300 min 18 8 (32.0%)
≥ 300 min 29 8 (36.4%)
Intraoperative blood infusion 0.753
With 25 8 (32.0%)
Without 22 8 (36.4%)
Note that adjacent organs include the pancreas, duodenum, stomach, and/or
colon other than the liver and bile duct.
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V in 6 patients using Clavien–Dindo classification [11].
Considering the lack of a significant difference in
mortality between the jaundiced patients and non-
jaundiced patients (p = 0.141), we focused on morbid-
ity. Univariate analysis showed that the risk factors for
morbidity were preoperative jaundice (34.0% vs. 12.4%,
p = 0.034) and intraoperative blood transfusion (34.1%
vs. 12.8%, p = 0.056). Multivariate analysis revealed
that preoperative jaundice was the only independent
predictor of postoperative morbidity.
Mortality and morbidity in 47 jaundiced GBC patients
(Table 3)
The postoperative mortality and morbidity rates in the
jaundiced patients were 6.4% (n = 3) and 34.0% (n = 16),
respectively. The causes of death were acute liver failure
(n = 1) followed by renal failure; intra-abdominal bleed-
ing (n = 1); and sepsis with multiorgan failure (n = 1).
Postsurgical complications were detected in 16 jaun-
diced patients. The most frequent complications were
intra-abdominal abscesses (n = 9), biliary leakage (n = 2),
intra-abdominal bleeding (n = 3), aspiration pneumonia
(n = 1), and liver failure (n = 1). These complications re-
quired an invasive procedure in 13 patients (reoperation:
n = 2, ultrasound guided drainage: n = 11). The average
postoperative hospital stay of the jaundiced patients was
19.7 d (range: 4-85 d), which was longer than that of the
non-jaundiced patients (p < 0.001). Univariate analysis
identified no risk factor for postoperative morbidity
among the jaundiced patients.
Survival and risk factors in 192 GBC patients who
underwent curative intent procedures (Tables 4 and 5)
Overall, the three- and five-year survival rates and me-
dian survival time for the 192 patients were 35.3%,
28.1%, and 37.0 months, respectively (Figure 3). Survival
curves for the 192 patients, grouped according to pre-
operative jaundice status, are shown in Figure 4. The
five-year survival rate and median survival time were
6.0% and 14.0 months for the 47 jaundiced patients, re-
spectively, and 36.0% and 43.0 months for the 145 non-
jaundiced patients, respectively. The jaundiced patients
had significantly lower survival rates than the non-
jaundiced patients (p < 0.001).
Univariate and multivariate analyses were performed
on the 192 GBC patients who received surgical resection
with curative intent to identify the factors that influence
long-term survival (Tables 4 and 5). Univariate analysis
revealed that the significant risk factors of survival were
age (p = 0.012), preoperative jaundice (p < 0.001), curative
resection (p < 0.001), tumor location (p < 0.001), pT factor
(p < 0.001), lymph node metastasis (p < 0.001), hepatic inva-
sion (p < 0.001), CRAO (p < 0.001), combined portal vein/hepatic artery resection (p = 0.041), and intraoperative
blood transfusion (p = 0.011) (Tables 4). Multivariate ana-
lysis was performed to determine which univariate prog-
nostic relationships are independent predictive factors.
Lymph node metastasis and tumors at the gallbladder neck
were the significant risk factors of poor prognosis in this
analysis (Table 5).
The patients who underwent CRAO had significantly
lower survival rates than those who did not undergo the
procedure (p < 0.001). The patients who underwent R0 re-
section had a higher five-year survival rate than those who
Table 4 Univariate analysis of 14 variables related to
survival of GBC patients who underwent surgical
resection with curative intent (n = 192)
Variable Cutoff level Number Survival rates (%) p-value
3 year 5 year
Age (year) 0.012
< 60 107 43.2 39.0
≥ 60 85 25.5 15.3
Sex 0.805
Male 66 34.9 24.4
Female 126 35.9 29.7
Jaundice < 0.001
Present 47 6.0 6.0
Absent 145 42.9 36.0
Associated gallstone 0.577
Present 106 35.3 25.8
Absent 86 35.3 30.9
Curability < 0.001
Curative 163 40.4 32.1
Non-curative 29 7.9 7.9
Tumor location < 0.001
Gallbladder neck 54 12.7 9.5
Gallbladder body/fundus 138 44.0 35.9
pT (TNM) < 0.001
pT1 and 2 95 57.4 49.5
pT3 and 4 97 12.8 6.4
Lymph node metastasis < 0.001
Negative 90 55.1 43.5
Positive 102 17.5 14.6
Histologic differentiation 0.154
Well/Moderate 161 36.0 30.8
Poor 31 32.1 11.5
Hepatic invasion < 0.001
Present 90 14.2 6.7
Absent 102 53.1 45.9
CRAO < 0.001
Present 15 0.0 0.0




Present 5 0.0 0.0
Absent 187 37.8 30.1
Intraoperative blood infusion 0.011
Present 44 16.6 5.5
Absent 148 41.1 35.2
Adjuvant therapy 0.782
Table 4 Univariate analysis of 14 variables related to
survival of GBC patients who underwent surgical
resection with curative intent (n = 192) (Continued)
Yes 28 31.6 13.2
No 164 35.8 30.4
Overall 192 35.3 28.1
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analysis revealed that neither CRAO nor R1 resection was
an independent predictor of poor prognosis. The jaundiced
patients had significantly lower survival rates than the non-
jaundiced patients (p < 0.001) (Figure 4). However, multi-
variate analysis demonstrated that preoperative jaundice
was not a significant risk factor (p = 0.295).Survival and risk factors in 47 jaundiced GBC patients
(Table 6)
The one- and three-year survival rates and median
survival time of the 47 jaundiced patients were 37.8%,
6.0%, and 14.0 months, respectively. Univariate analysis
was performed on the 47 jaundiced patients who re-
ceived surgical resection with curative intent to identify
the factors that influence the long-term survival of these
patients (Table 6). The patients who underwent R0 re-
section survived longer than those who underwent R1
resection (p = 0.004). Multivariate analysis showed that
R1 resection was the only independent predictor of poor









Age 0.287 0.189 0.129 1.332 0.920–
1.928
Jaundice −0.289 0.277 0.295 0.749 0.435–
1.287
Curability 0.166 0.260 0.523 1.181 0.709–
1.965
Tumor location −0.691 0.231 0.003 0.501 0.318–
0.788




−0.453 0.225 0.044 0.636 0.409–
0.987
Hepatic invasion −0.641 0.384 0.095 0.527 0.248–
1.119









−0.347 0.246 0.159 0.707 0.436–
1.145
Figure 3 Actuarial survival curve of 192 gallbladder cancer patients following surgical resection with curative intent.
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without PBD (Table 7)
After PBD, direct bilirubin decreased from 216.5 ±
131.9 mol/L to 116.9 ± 66.3 mol/L (p < 0.001) with de-
creasing AST and ALT levels. Overall, the one- and
three-year survival rates were 37.9% and 6.3% in the
jaundiced patients with PBD (n = 19), respectively, and
38.5% and 8.7% in the jaundiced patients without PBD
(n = 28), respectively. The primary endpoint of the
three-year survival after surgery was not significantly dif-
ferent between the groups. The survival rates of the
jaundiced patients with PBD were similar to those of the
jaundiced patients without PBD (p = 0.968). The only
patient who died of liver failure within the first 30 d
postsurgery was a jaundiced GBC patient without PBD.
The rate of postoperative intra-abdominal abscesses
was not significantly different between the jaundiced
patients with and without PBD (n = 4, 21.1% vs. n = 5,
17.9%, p = 0.787).Figure 4 Actuarial survival curve according to preoperative jaundiceDiscussion and conclusions
Preoperative jaundice is an indicator of advanced GBC
with poor prognosis [1-4]. The present study con-
firmed that jaundiced patients had more postoperative
complications (34.0% and 12.4%, p = 0.001) and lower
five-year survival rates than non-jaundiced patients (6.0%
and 36.0%, p < 0.001). However, multivariate analysis
showed that preoperative jaundice was not a significant risk
factor of poor outcome (p = 0.295). The present study in-
volved 192 GBC patients who underwent resection with
curative intent. R0 resection was performed in 163 patients.
This study is one of the largest investigations that have ever
been published.
Implication of PBD before resection for advanced GBC
with preoperative jaundice
Preoperative liver optimization has been a subject of de-
bates for the last two decades, especially in PBD [12]. A
prospective cohort study found that PBD significantly(with vs. without jaundice: p < 0.001).
Table 6 Univariate and multivariate analyses of 14 variables related to survival of GBC patients with preoperative
jaundice (n = 47)
Variable Cutoff level Number Survival rates (%) Univariate Multivariate
1 year 3 year p-value RR (95% CI) P
Age (year) 0.980
< 60 26 42.1 8.0
≥ 60 221 25.5 15.3
Sex 0.477
Male 21 36.6 24.4
Female 26 39.6 29.7
Preoperative biliary drainage 0.968
Present 19 37.9 6.3
Absent 28 38.5 8.7
Associated gallstone 0.341
Present 26 53.8 11.5
Absent 21 54.5 0.0
Curability 0.004 2.845 (1.314–6.158) 0.008
Curative 36 47.0 7.2
Non-curative 11 9.1 0.0
Tumor location 0.699
Gallbladder neck 28 42.5 8.5
Gallbladder body/fundus 19 30.7 0.0
pT (TNM) 0.170
pT1 and 2 16 42.2 12.7
pT3 and 4 31 35.2 4.4
Lymph node metastasis 0.328
Negative 17 47.1 7.8
Positive 30 32.2 10.1
Histologic differentiation 0.432
Well/Moderate 43 38.8 6.0
Poor 4 25.0 0.0
Hepatic invasion 0.728
Present 26 30.5 6.1
Absent 21 46.2 8.8
CRAO 0.728
Present 11 43.6 0.0
Absent 36 35.9 7.2
Intraoperative blood infusion 0.893
Present 25 34.5 12.9
Absent 22 41.5 0.0
Adjuvant therapy 0.179
Yes 7 51.4 25.7
No 40 35.6 4.9
Overall 47 37.8 6.0
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Table 7 Compared analyses for jaundiced patients with and without PBD (n = 47)
Variables With PBD,n = 19 Without PBD, n = 28 p-value
Male gender 6 15 0.141
Mean age (range) 55.2 ± 11.1 59.0 ± 10.9 0.247
Postoperative hospital stay 18.8 ± 9.1 20.4 ± 15.6 0.689
Bilirubin level at presentation 234.0 ± 120.5 194.4 ± 125.7 0.287
Intra-operative bleeding (mL) 800.0 ± 761.4 723.2 ± 475.6 0.672
Operative time (min) 328.9 ± 77.7 297.1 ± 84.8 0.199
R0 15 (78.9) 21 (75.0) 0.795
Mortality (number of patients) 1 (5.3%) 2 (7.1%) 0.854
Morbidity (need invasive treatment) 6 (31.6%) 10 (35.7%) 0.755
Intra-abdominal abscesses 4 (21.1%) 5 (17.9%) 0.787
Survival 0.968
One-year survival 37.9% 38.5%
Three-year survival 6.3% 8.7%
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study concluded that the routine use of PBD was not justi-
fied, considering that the mortality rate was not signifi-
cantly different and the hepatic synthetic function recovery
was identical to those of non-jaundiced patients [13]. To
date, a few randomized controlled trials or meta-analyses
have been conducted to systematically evaluate the value of
PBD for the surgical resection of advanced GBC with pre-
operative jaundice. In the present study, the only patient
who died of liver failure was a jaundiced GBC patient with-
out PBD. Moreover, the postoperative mortality rates were
not significantly different between the jaundiced patients
with and without PBD.
Biliary obstruction is associated with renal failure,
body fluid disturbances, and myocardial dysfunction.
In our population, preoperative jaundice was a signifi-
cant prognostic factor (p < 0.001) (Figure 4), which was
consistent with the results our previous study [14]. We
proposed that PBD via PTBD improves preoperative
liver function; however, the effect of PBD on postoper-
ative infection risk remains to be clarified [15-19]. In
the present study, the decrease in the bilirubin level
was statistically relevant (p < 0.001). However, this
benefit was not associated with a longer survival time
(p = 0.968).
Intra-abdominal abscesses often directly precede liver
failure; thus, several researchers have shown that PTBD
and increased intra-abdominal abscesses are significantly
related [12,16]. However, no significant differences in
the rates of postoperative intra-abdominal abscesses were
detected between jaundiced patients with and without PBD
(21.1% vs. 17.9%, respectively, p = 0.787). Univariate analysis
showed that PBD was not a risk factor for postoperative
complications in jaundiced patients.Liver surgery in jaundiced patients is supposed to have
particular risks because of the hepatic and systemic
changes caused by hyperbilirubinemia [15,18]. Experi-
mental studies on jaundiced animals have shown the
benefits of biliary drainage, especially of internal biliary
drainage with the restoration of biliary salt enterohepatic
circulation [20]. PBD should increase cholestatic liver
tolerance to ischemia [21] and reduce blood loss [22].
However, such benefits were not observed through the
postoperative mortality and morbidity rates in jaundiced
patients, which was not consistent with the results of
previous studies [12,23]. The lack of postoperative liver
failure in the present study may be attributed to the low
frequency of additional major surgical procedures, such
as major hepatectomy and pancreaticoduodenectomy.
Preoperative jaundice as an indicator of poor prognosis
and high postoperative morbidity but not a surgical
contraindication
Jaundice is an indicator of advanced GBC with poor
prognosis [1-4]. In the present study, the jaundiced pa-
tients had longer postoperative hospital stay and lower
five-year survival rates than the non-jaundiced patients
(6.0% and 36.0%, respectively). However, multivariate
analysis revealed that preoperative jaundice was not a
significant risk factor of poor outcome. Therefore, we
have not solely considered jaundice to be a surgical
contraindication. Several jaundiced patients had in-
creased survival rates following resection. However, in
the present study, preoperative jaundice was the only in-
dependent predictor of postoperative morbidity in GBC
patients. Clinicians should be aware of this finding.
Several recent articles have been published with en-
couraging results. Agarwal et al. [14] reported that the
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http://www.biomedcentral.com/1471-2407/14/652presence of obstructive jaundice caused by GBC is nei-
ther a sole indicator of advanced disease nor a surgical
contraindication. D’Angelica et al. [4] reported a five-
year survival rate of 20% and a median survival time of
19 months after resection of GBC with clinical common
bile duct involvement. They concluded that advanced
GBC patients with preoperative jaundice and/or pEBI
are candidates for resection when distant metastases are
absent and R0 resection is achievable. This finding is
consistent with the results of Hideki Nishio [9] and our
previous report [24]. In the present study, the non-
jaundiced patients, even those with locally advanced
(T3/T4) GBC, exhibited good prognosis. Our data are
consistent with the findings of Nishio et al. [9] and
Agarwal et al. [14]. Multivariate analysis showed that
non-curative resection was the only independent pre-
dictor of poor prognosis in jaundiced GBC patients.
Therefore, even advanced GBC patients with preopera-
tive jaundice should be resected whenever R0 resection
is achievable.
In the present study, multivariate analysis of all 192
GBC patients revealed that lymph node metastasis and
gallbladder neck tumors were independent prognostic
factors. Therefore, an extended dissection of the regional
lymph nodes must be routinely performed to achieve
good prognosis. However, no specific patterns between
recurrence incidence and gallbladder neck tumors were
found. In addition, the mechanism by which gallbladder
neck tumors contribute to GBC progression remains un-
known. One possible explanation is that the gallbladder
neck is in an anatomically “busy” area because of in-
volved adjoining bile duct, portal vein, liver, duodenum,Figure 5 Actuarial survival curve according to tumor location (gallblaand colon, making surgical resection and radiotherapy
difficult [24,25]. Gallbladder neck tumors significantly
increase surgical difficulty and reduce the opportunities
for radical resection. Meanwhile, a relatively small tumor
in the gallbladder neck infiltrates the hepatic hilum, thus
causing obstructive jaundice [26]. In conclusion, ad-
vanced GBC with extrahepatic bile duct invasion and/or
jaundice is a candidate for resection when R0 resection
is achievable. However, the radical resection of advanced
gallbladder neck cancer is still challenging with high
postoperative morbidity and poor prognosis (Figure 5).Extended resection for advanced GBC
Treatment of advanced GBC requires combined resec-
tion because it usually extends into adjacent organs, such
as the liver, transverse colon, duodenum, extrahepatic bile
duct, HA, and PV. For advanced GBC, extended resections
that include extended hepatectomy, pancreatoduodenect-
omy, extended lymph node dissection, and combined vas-
cular resection have been recently performed [27-29].
Extended resections have a high surgical mortality rate, and
patients who have undergone such surgery remain to have
poor prognosis [30-32]. The benefit of radical resection is
apparently limited in advanced GBC patients. Hence, iden-
tifying patients who will potentially benefit from aggressive
resection is important. Understanding the limits of the
current surgical therapies may save patients with aggressive
tumors from high morbidity and mortality rates related to
surgeries that are unlikely to offer any benefit. It also allows
patients and physicians to focus on palliation to improve
the patients’ quality of life.dder neck vs. gallbladder body/fundus: p < 0.001).
Yang et al. BMC Cancer 2014, 14:652 Page 12 of 13
http://www.biomedcentral.com/1471-2407/14/652CRAO other than the liver and extrahepatic bile duct
was an independent predictor of poor prognosis (p =
0.041). No three-year survivors were found among the
patients undergoing CRAO, although CRAO was not a
significant risk factor for poor outcome in multivariate
analysis (Table 5). Therefore, aggressive resection should
be carefully planned in patients who require CRAO. Our
data are also consistent with the findings of Nishio [9].
Considering the high risk of death and poor long-
term survival, we found no definitive benefit from
the extended resections for advanced GBC [30]. A par-
enchymal preservation strategy has been investigated
on the basis of the results published by Agarwal et al.
[14]. A similar strategy for minor resection has been
recently recommended by Regimbeau [8] for jaundiced
patients with GBC. In the present study, we retained
the most normal liver parenchyma to reduce the inci-
dence of postoperative complications from R0 resec-
tion. We also obtained a comparable five-year survival
rate and relatively low mortality and morbidity rates.
Therefore, we recommend minor resection when a
negative margin is ensured during operation.
This study has some limitations. Despite the large
number of patients included in the present study, the
patients were a highly selected cohort and represent
only a fraction of the total number of jaundiced GBC
patients diagnosed during the study period. Additional
investigations with a large patient population in a mul-
ticenter study are needed before definitive conclusions
can be drawn. Further studies must be conducted to
clarify the resection contraindications in advanced
GBC patients.
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